# Dose Finding Study of Post-BMT Decitabine Maintenance Treatment in Higher-risk MDS and MDS/AML

> **NCT01277484** · PHASE1 · UNKNOWN · sponsor: **Seoul St. Mary's Hospital** · enrollment: 19 (actual)

## Conditions studied

- Myelodysplastic Syndrome
- Acute Myeloid Leukemia

## Interventions

- **DRUG:** Decitabine

## Key facts

- **NCT ID:** NCT01277484
- **Lead sponsor:** Seoul St. Mary's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-01
- **Primary completion:** 2014-09
- **Final completion:** 2015-12
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2015-11-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01277484

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01277484, "Dose Finding Study of Post-BMT Decitabine Maintenance Treatment in Higher-risk MDS and MDS/AML". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01277484. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*